Argenx
ARGX
#405
Rank
โ‚น6.104 T
Marketcap
โ‚น98,165
Share price
0.83%
Change (1 day)
57.60%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: โ‚น6.104 Trillion

As of August 2026 Argenx has a market cap of โ‚น6.104 Trillion. This makes Argenx the world's 405th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น6.104 T29.24%
2025โ‚น4.723 T47.02%
2024โ‚น3.212 T71.02%
2023โ‚น1.878 T8.32%
2022โ‚น1.734 T26.7%
2021โ‚น1.368 T33.48%
2020โ‚น1.025 T109.06%
2019โ‚น490.51 B100.08%
2018โ‚น245.15 B91.51%
2017โ‚น128.01 B
2014โ‚น9.22 B

End of Day market cap according to different sources

On Aug 30th, 2026 the market cap of Argenx was reported to be:

โ‚น6.042 Trillion
by Nasdaq info icon info icon
โ‚น6.054 Trillion
by CompaniesMarketCap info icon info icon